MedPath

Preclinical study of intermittent pneumatic therapy for early neurological deterioration in patients with acute cerebral infarction and investigation of its mechanism

Phase 1
Completed
Conditions
Ischemic stroke
Registration Number
ChiCTR2400088964
Lead Sponsor
Guangdong Second Provincial General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1)Age = 18 years old<br>2)Modified Rankin Scale (mRS) score of 0-1 before stroke<br>3)Acute ischemic anterior circulation stroke, and onset within 72 hours<br>4)CT and/or MR confirmation of ischemic stroke.

Exclusion Criteria

1)Intracranial hemorrhage<br>2)Severe limb infection that has not been effectively controlled<br>3)Recent deep vein thrombosis of the lower extremities<br>4)Large area of ulcerative rash<br>5)Bleeding tendency, malignant tumor, and psychiatric illness are not eligible<br>6)Severe aortic calcification, aneurysm, and poor blood pressure control<br>7)The researchers believe that other reasons are not suitable for clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Early neurologic deterioration;
Secondary Outcome Measures
NameTimeMethod
mRS score at 3 months after discharge;Ischemic stroke at 3 months;Other vascular events and death;
© Copyright 2025. All Rights Reserved by MedPath